Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F1CYY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,972
Award facts
- Contract value 100% obligated
- $39,972.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on July 13, 2026, for Cosentyx (ixekizumab) 300 mg pen 2 ml, with a ceiling value of $39,972.22. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical indefinite delivery contract. Ultimate completion is scheduled for July 14, 2026. Pricing is firm fixed-price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26F1CYY?
SPE2DR26F1CYY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 13, 2026.
How much is contract SPE2DR26F1CYY worth?
The government has obligated $39,972 on SPE2DR26F1CYY.
Is contract SPE2DR26F1CYY an order under another contract?
Yes. SPE2DR26F1CYY is a delivery order under SPE2DR25D2012, an indefinite delivery contract.
Was contract SPE2DR26F1CYY competed?
The extent of competition for SPE2DR26F1CYY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award